Medication info

M2Caine Cream

Prescription medicationCreamExpired
Ingredient · strength
Lidocaine›25mg / 1gPrilocaine›25mg / 1g
Manufacturer / importer
Macnulty Pharmaceutical Co., Ltd.
Appearance
White cream
Packaging
500 grams/container
Approval status
Expired

MFDS item code 200800998 · Notified 2008.01.24

This product's status changed to Expired on 2025.10.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Relief of pain through surface anesthesia of the skin, genital mucosa, and leg ulcers
Who uses it
Adults · Children
Adult dosage
○ Adults 1. Skin: After applying this medicine, cover the area with an occlusive dressing. Occlusion of the application site should generally be maintained for 1-3 hours, and the effect persists for at least 1 hour after removal of the occlusive dressing. 1) For needle insertion (e.g., venous cannulation, blood collection), apply approximately 2g of this medicine for at least 1 hour and up to 5 hours. 2) For minor superficial surgery (e.g., curettage of molluscum contagiosum), apply 1.5-2g/10cm2 for 1 hour. 3) For major superficial surgery (e.g., split-thickness skin grafting), apply 1.5-2g/10cm2 for at least 2 hours and up to 5 hours. 2. Genital mucosa: For removal of condylomata, apply approximately 5~10g of this medicine to the treatment site for 5-10 minutes, then remove the medicine and begin the procedure immediately. 3. Leg ulcers: After applying this medicine, cover the area with an occlusive dressing. Use an opened tube for a single application and discard any remaining cream after each procedure. Apply 1~2g/10cm2 for at least 30 minutes, not exceeding 10g per treatment. For leg ulcers with tissue that is difficult to penetrate, the application time may be extended to 60 minutes; clean the ulcer within 10 minutes after removing the cream. No decrease in efficacy or increase in local reactions was observed when used up to 15 times over 1~2 months.
Children's dosage
○ Infants aged 3 months-12 months: Total amount 2g; do not exceed an application area of 16cm2.

Ingredients

Manufacturer
Macnulty Pharmaceutical Co., Ltd.

Efficacy & effects

Relief of pain through surface anesthesia of the skin, genital mucosa, and leg ulcers

View approved original text

This medication is used to anesthetize the surface of the skin during the insertion of a needle and superficial surgical procedures. It is also effective for surface anesthesia of the genital mucosa, for example, prior to the removal of condylomas. Additionally, it is used for the cleaning of leg ulcers, superficial surgeries, and the removal of fibrin or pus and necrotic tissue, helping to reduce patient pain. It is utilized for various surface anesthetic purposes, enhancing patient convenience and supporting therapeutic effects.

Dosage and Administration

Adult dosage

○ Adults 1. Skin: After applying this medicine, cover the area with an occlusive dressing. Occlusion of the application site should generally be maintained for 1-3 hours, and the effect persists for at least 1 hour after removal of the occlusive dressing. 1) For needle insertion (e.g., venous cannulation, blood collection), apply approximately 2g of this medicine for at least 1 hour and up to 5 hours. 2) For minor superficial surgery (e.g., curettage of molluscum contagiosum), apply 1.5-2g/10cm2 for 1 hour. 3) For major superficial surgery (e.g., split-thickness skin grafting), apply 1.5-2g/10cm2 for at least 2 hours and up to 5 hours. 2. Genital mucosa: For removal of condylomata, apply approximately 5~10g of this medicine to the treatment site for 5-10 minutes, then remove the medicine and begin the procedure immediately. 3. Leg ulcers: After applying this medicine, cover the area with an occlusive dressing. Use an opened tube for a single application and discard any remaining cream after each procedure. Apply 1~2g/10cm2 for at least 30 minutes, not exceeding 10g per treatment. For leg ulcers with tissue that is difficult to penetrate, the application time may be extended to 60 minutes; clean the ulcer within 10 minutes after removing the cream. No decrease in efficacy or increase in local reactions was observed when used up to 15 times over 1~2 months.

Children's dosage

○ Infants aged 3 months-12 months: Total amount 2g; do not exceed an application area of 16cm2.

Precautions

This drug is used as a local anesthetic and may cause a rare side effect known as methemoglobinemia. Methemoglobinemia is a condition characterized by reduced oxygen transport capacity in the blood, which may result in bluish discoloration of the skin or abnormal blood coloration. Patients with glucose-6-phosphate dehydrogenase deficiency, congenital methemoglobinemia, heart or lung diseases, infants under 6 months of age, and those taking oxidizing agents are more sensitive to this condition and should exercise caution. This drug should not be used by individuals with hypersensitivity to amide-based local anesthetics, as well as patients with open wounds, mucosal conditions, contact dermatitis, or atopic dermatitis. It is also not safe to administer to infants under 3 months old or infants under 12 months taking medications that cause methemoglobinemia, as well as preterm infants born before 37 weeks of gestation. Caution is required when using this drug in patients with anemia or liver disease, elderly individuals, and frail patients, especially those allergic to propylene glycol. Local reactions, such as transient skin erythema, swelling, itching, and burning sensations may occur, and in rare cases, severe allergic reactions or anaphylaxis may develop. Contact with the eyes may cause irritation, so it should not be used around the eyes, and if it accidentally enters the eyes, it should be immediately rinsed with water or saline. This product should not be used in the ear or on areas with open lesions. In the case of excessive use, symptoms of methemoglobinemia and central nervous system and cardiovascular abnormalities may appear, requiring immediate treatment. The risk to the fetus during pregnancy has not been reported, but it should be used cautiously only when necessary. Caution is also required during breastfeeding as some components may be excreted in breast milk. Use in children, especially infants under 3 months of age, is limited and should be approached with special caution, and it is advisable not to apply it to genital mucosa. Using this drug in combination with other local anesthetics or specific medications may increase the risk of toxicity, so it is essential to consult with a doctor or pharmacist when used concurrently. It is important to closely monitor the patient's condition before and after use, and report any adverse reactions immediately to healthcare professionals.

Side effects

  • Pallor
  • erythema
  • edema
  • mild initial burning sensation
  • pruritus
  • purpura
  • petechiae
  • methemoglobinemia
  • allergic reactions
  • anaphylactic shock
Show 3 more
  • corneal irritation
  • paresthesia
  • skin irritation

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a tightly sealed container to protect it from air and moisture. It is recommended to maintain the storage temperature between 1 and 30 degrees Celsius. Storing it this way will help to ensure the drug's efficacy and safety.

Appearance and packaging

Appearance

White cream

Package unit

500 grams/container

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.